Table of Contents

- R C Perry and
- A D Baron
Impaired glucose tolerance. Why is it not a disease?
Diabetes Care June 1999 22:883-885; doi:10.2337/diacare.22.6.883
- Full Text (PDF)
- B Gumbiner
Treating obesity in type 2 diabetes. Calories, composition, and control.
Diabetes Care June 1999 22:886-888; doi:10.2337/diacare.22.6.886
- Full Text (PDF)
Select this article
- L K Heilbronn,
- M Noakes,
- and P M Clifton
Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.
Diabetes Care June 1999 22:889-895; doi:10.2337/diacare.22.6.889
- Abstract
- Full Text (PDF)
Select this article
- J B Redmon,
- S K Raatz,
- C A Kwong,
- J E Swanson,
- W Thomas,
- and J P Bantle
Pharmacologic induction of weight loss to treat type 2 diabetes.
Diabetes Care June 1999 22:896-903; doi:10.2337/diacare.22.6.896
- Abstract
- Full Text (PDF)
Select this article
- M Bouma,
- J H Dekker,
- J J de Sonnaville,
- F E van der Does,
- H de Vries,
- D M Kriegsman,
- P J Kostense,
- R J Heine,
- and J T van Eijk
How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
Diabetes Care June 1999 22:904-907; doi:10.2337/diacare.22.6.904
- Abstract
- Full Text (PDF)
Select this article
- Y Mori,
- Y Murakawa,
- K Okada,
- H Horikoshi,
- J Yokoyama,
- N Tajima,
- and Y Ikeda
Effect of troglitazone on body fat distribution in type 2 diabetic patients.
Diabetes Care June 1999 22:908-912; doi:10.2337/diacare.22.6.908
- Abstract
- Full Text (PDF)
Select this article
- V Vuksan,
- D J Jenkins,
- P Spadafora,
- J L Sievenpiper,
- R Owen,
- E Vidgen,
- F Brighenti,
- R Josse,
- L A Leiter,
- and C Bruce-Thompson
Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.
Diabetes Care June 1999 22:913-919; doi:10.2337/diacare.22.6.913
- Abstract
- Full Text (PDF)
Select this article
- M Tominaga,
- H Eguchi,
- H Manaka,
- K Igarashi,
- T Kato,
- and A Sekikawa
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
Diabetes Care June 1999 22:920-924; doi:10.2337/diacare.22.6.920
- Abstract
- Full Text (PDF)
Select this article
- M Stang,
- D K Wysowski,
- and D Butler-Jones
Incidence of lactic acidosis in metformin users.
Diabetes Care June 1999 22:925-927; doi:10.2337/diacare.22.6.925
- Abstract
- Full Text (PDF)
Select this article
- P A McKinney,
- R Parslow,
- K A Gurney,
- G R Law,
- H J Bodansky,
- and R Williams
Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.
Diabetes Care June 1999 22:928-932; doi:10.2337/diacare.22.6.928
- Abstract
- Full Text (PDF)
Select this article
- E Kousta,
- N J Lawrence,
- A Penny,
- B A Millauer,
- S Robinson,
- A Dornhorst,
- M de Swiet,
- P J Steer,
- A Grenfell,
- H M Mather,
- D G Johnston,
- and M I McCarthy
Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.
Diabetes Care June 1999 22:933-937; doi:10.2337/diacare.22.6.933
- Abstract
- Full Text (PDF)
Select this article
- A J Karter,
- S E Rowell,
- L M Ackerson,
- B D Mitchell,
- A Ferrara,
- J V Selby,
- and B Newman
Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.
Diabetes Care June 1999 22:938-943; doi:10.2337/diacare.22.6.938
- Abstract
- Full Text (PDF)
Select this article
- D Dabelea,
- D J Pettitt,
- R L Hanson,
- G Imperatore,
- P H Bennett,
- and W C Knowler
Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.
Diabetes Care June 1999 22:944-950; doi:10.2337/diacare.22.6.944
- Abstract
- Full Text (PDF)
Select this article
- S E Moss,
- R Klein,
- and B E Klein
The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Diabetes Care June 1999 22:951-959; doi:10.2337/diacare.22.6.951
- Abstract
- Full Text (PDF)
Select this article
- R R Holman,
- C A Cull,
- and R C Turner
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
Diabetes Care June 1999 22:960-964; doi:10.2337/diacare.22.6.960
- Abstract
- Full Text (PDF)
Select this article
- J H Ahroni,
- E J Boyko,
- and R C Forsberg
Clinical correlates of plantar pressure among diabetic veterans.
Diabetes Care June 1999 22:965-972; doi:10.2337/diacare.22.6.965
- Abstract
- Full Text (PDF)
Select this article
- S Mäkimattila,
- M L Liu,
- J Vakkilainen,
- A Schlenzka,
- S Lahdenperä,
- M Syvänne,
- M Mäntysaari,
- P Summanen,
- R Bergholm,
- M R Taskinen,
- and H Yki-Järvinen
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Diabetes Care June 1999 22:973-981; doi:10.2337/diacare.22.6.973
- Abstract
- Full Text (PDF)
- R A Preston and
- M Epstein
Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.
Diabetes Care June 1999 22:982-988; doi:10.2337/diacare.22.6.982
- Full Text (PDF)
- Z T Bloomgarden
The European Association for the Study of Diabetes Annual Meeting, 1998. The U.K. Prospective Diabetes Study and other topics in type 2 diabetes.
Diabetes Care June 1999 22:989-995; doi:10.2337/diacare.22.6.989
- Full Text (PDF)
- H Ylihärsilä,
- J Tuomilehto,
- I R Mackay,
- P Zimmet,
- E Tuomilehto-Wolf,
- M J Rowley,
- and A Nissinen
GAD antibodies in elderly men in different categories of glucose tolerance.
Diabetes Care June 1999 22:996-997; doi:10.2337/diacare.22.6.996
- Full Text (PDF)
- J A Hänninen,
- J K Takala,
- and S M Keinänen-Kiukaanniemi
Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life.
Diabetes Care June 1999 22:997-998; doi:10.2337/diacare.22.6.997
- Full Text (PDF)
- E Casey,
- A Evans,
- A Krentz,
- P Watkins,
- and D Hopkins
Central pontine myelinolysis. An unusual complication of diabetes.
Diabetes Care June 1999 22:998-1000; doi:10.2337/diacare.22.6.998
- Full Text (PDF)
- D S Bell and
- F Ovalle
Gastroparesis cured by gastrectomy.
Diabetes Care June 1999 22:1000-1001; doi:10.2337/diacare.22.6.1000
- Full Text (PDF)
- P Belicar,
- N Jeandidier,
- E Renard,
- S Boivin,
- P Gross,
- M Pinget,
- and V Lassmann-Vague
Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.
Diabetes Care June 1999 22:1001-1002; doi:10.2337/diacare.22.6.1001
- Full Text (PDF)
- B Gatta,
- V Rigalleau,
- and H Gin
Diabetic ketoacidosis with olanzapine treatment.
Diabetes Care June 1999 22:1002-1003; doi:10.2337/diacare.22.6.1002
- Full Text (PDF)
- E Raynaud,
- A Perez-Martin,
- J F Brun,
- A A Benhaddad,
- and J Mercier
Revised concept for the estimation of insulin sensitivity from a single sample.
Diabetes Care June 1999 22:1003-1004; doi:10.2337/diacare.22.6.1003
- Full Text (PDF)
- Y Nagai,
- T Takamura,
- E Nohara,
- H Yamashita,
- and K Kobayashi
Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.
Diabetes Care June 1999 22:1004; doi:10.2337/diacare.22.6.1004b
- Full Text (PDF)
- L Blonde,
- M I Sandberg,
- and R D Guthrie, Jr
Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Diabetes Care June 1999 22:1004-1006; doi:10.2337/diacare.22.6.1004a
- Full Text (PDF)
- J F Navarro and
- C Mora
Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.
Diabetes Care June 1999 22:1006-1008; doi:10.2337/diacare.22.6.1006
- Full Text (PDF)
- F Hunkert,
- T Lietz,
- B Stach,
- and W Kiess
Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.
Diabetes Care June 1999 22:1008-1010; doi:10.2337/diacare.22.6.1008
- Full Text (PDF)
- R D Cohen and
- H F Woods
Metformin and lactic acidosis.
Diabetes Care June 1999 22:1010-1011; doi:10.2337/diacare.22.6.1010
- Full Text (PDF)
- M Fukui,
- N Nakamura,
- and M Kondo
GAD antibodies in classification of Asian type 2 diabetes.
Diabetes Care June 1999 22:1011-1012; doi:10.2337/diacare.22.6.1011
- Full Text (PDF)
- P Gunczler and
- R Lanes
Poor metabolic control decreases the growth velocity of diabetic children.
Diabetes Care June 1999 22:1012; doi:10.2337/diacare.22.6.1012
- Full Text (PDF)

Impaired glucose tolerance. Why is it not a disease?

Treating obesity in type 2 diabetes. Calories, composition, and control.

Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.

Pharmacologic induction of weight loss to treat type 2 diabetes.

How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

Effect of troglitazone on body fat distribution in type 2 diabetic patients.

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

Incidence of lactic acidosis in metformin users.

Perinatal and neonatal determinants of childhood type 1 diabetes. A case-control study in Yorkshire, U.K.

Implications of new diagnostic criteria for abnormal glucose homeostasis in women with previous gestational diabetes.

Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry.

Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults.

The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

Clinical correlates of plantar pressure among diabetic veterans.

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.

Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications.

The European Association for the Study of Diabetes Annual Meeting, 1998. The U.K. Prospective Diabetes Study and other topics in type 2 diabetes.

GAD antibodies in elderly men in different categories of glucose tolerance.

Depression in subjects with type 2 diabetes. Predictive factors and relation to quality of life.

Central pontine myelinolysis. An unusual complication of diabetes.

Gastroparesis cured by gastrectomy.

Implanted insulin pump may represent a chance for young women with unstable type 1 diabetes to give birth.

Diabetic ketoacidosis with olanzapine treatment.

Revised concept for the estimation of insulin sensitivity from a single sample.

Acute hyperinsulinemia reduces plasma concentrations of homocysteine in healthy men.

Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.

Antiproteinuric effect of pentoxifylline in patients with diabetic nephropathy.

Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes.

Metformin and lactic acidosis.

GAD antibodies in classification of Asian type 2 diabetes.

Poor metabolic control decreases the growth velocity of diabetic children.

This Issue

Current Issue

From the Cover